Intelligent Investment
Beijing Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read

Overview
- Beijing is one of China’s two comprehensive life sciences clusters, alongside Shanghai, that offer a spectrum of research and development (R&D), manufacturing, medical technology and front office or headquarters space.
- Beijing has developed three life sciences clusters throughout past 20 years: Zhongguancun (ZGC) Life Sciences Park, China Bio-medicine Park (CBP) and Beijing Economic-Technological Development Area (BDA). ZGC Life Sciences Park, located in northern Beijing, is R&D-focused, while BDA and CBP in southern Beijing integrate R&D and manufacturing. All three have mixed ownership comprised of owner-occupied properties, private development and government.
- Zhongguancun Life Science Park benefits from nearby top universities and research institutes and plans significant expansion. China Bio-Medicine Park, a newer offering, began leasing in 2020.
Submarkets
Figure 1: Beijing Inventory of Leasable Life Sciences Space
Life Sciences Venture Capital Investment Trends
Figure 2: Life Sciences Venture Capital Funding
Life Sciences Market Stats
Figure 3: Life Sciences Market Stats
Development Pipeline or Activity
Figure 4: Beijing Projected Future Supply of Life Sciences Space (2024-2026)
- BeiGene
- Berry Genomics
- Bestnovo
- Biocytogen
- China Resources
- FutureGen
- Hengrui Pharmaceutical
- InnoCare Pharma
- Novo Nordisk
- Pharmaron
- Pyrotech
- Singlomics
- Peking Union Medical College
- Peking University
- Tsinghua University
- University of the Chinese Academy of Sciences